Ameritas Investment Partners’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.1K Hold
585
﹤0.01% 2754
2025
Q4
$12.3K Hold
585
﹤0.01% 2846
2025
Q3
$5.82K Hold
585
﹤0.01% 3045
2025
Q2
$5.31K Hold
585
﹤0.01% 3100
2025
Q1
$5.58K Hold
585
﹤0.01% 2950
2024
Q4
$6.57K Hold
585
﹤0.01% 2992
2024
Q3
$8.41K Hold
585
﹤0.01% 2966
2024
Q2
$10.1K Buy
+585
New +$8.55K ﹤0.01% 2927
2022
Q2
Sell
-316
Closed -$6K 3131
2022
Q1
$6K Hold
316
﹤0.01% 2930
2021
Q4
$8K Hold
316
﹤0.01% 2958
2021
Q3
$12K Hold
316
﹤0.01% 2888
2021
Q2
$14K Buy
+316
New +$11.9K ﹤0.01% 2866

Other funds holding GLSI

Ameritas Investment Partners's GLSI Position: Q1 2026 in Review

Ameritas Investment Partners held its Greenwich LifeSciences (GLSI) position steady in Q1 2026 at 585 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2754.

Ameritas Investment Partners first reported a position in GLSI in Q2 2021 and has held it in 12 quarters since. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • Ameritas Investment Partners held 585 shares of Greenwich LifeSciences worth $14.1K as of Q1 2026.
  • Ameritas Investment Partners left its Greenwich LifeSciences share count unchanged in Q1 2026.
  • Greenwich LifeSciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2754 holding.
  • Ameritas Investment Partners first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 12 quarters since.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.